Reported number of people receiving antiretroviral therapy in Mauritania
Mauritania: Reported number of people receiving antiretroviral therapy was 4,681 in 2025. ◆ Volatile
Reported number of people receiving antiretroviral therapy in Mauritania, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Mauritania recorded 4,681 for reported number of people receiving antiretroviral therapy in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 3.7% on the previous year and up 90.4% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Mauritania peaked at 4,681 in 2025 and was at its lowest, 2, in 2000.
That places Mauritania 104th out of 143 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Reported number of people receiving antiretroviral therapy in Mauritania, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 2 | — |
| 2001 | 4 | +100.0% |
| 2002 | 9 | +125.0% |
| 2003 | 19 | +111.1% |
| 2004 | 71 | +273.7% |
| 2005 | 254 | +257.7% |
| 2006 | 523 | +105.9% |
| 2007 | 845 | +61.6% |
| 2008 | 1,107 | +31.0% |
| 2009 | 1,417 | +28.0% |
| 2010 | 1,619 | +14.3% |
| 2011 | 1,738 | +7.4% |
| 2012 | 1,830 | +5.3% |
| 2013 | 2,143 | +17.1% |
| 2014 | 2,263 | +5.6% |
| 2015 | 2,458 | +8.6% |
| 2016 | 2,615 | +6.4% |
| 2017 | 3,021 | +15.5% |
| 2018 | 3,032 | +0.4% |
| 2019 | 3,273 | +7.9% |
| 2020 | 3,384 | +3.4% |
| 2021 | 3,623 | +7.1% |
| 2022 | 3,755 | +3.6% |
| 2023 | 4,216 | +12.3% |
| 2024 | 4,516 | +7.1% |
| 2025 | 4,681 | +3.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 425.1 | 2 | 1,417 | 10 |
| 2010s | 2,399 | 1,619 | 3,273 | 10 |
| 2020s | 4,029 | 3,384 | 4,681 | 6 |
Countries ranked near Mauritania
More health data for Mauritania
- Un projection of annual infant deaths, annual growth rate -0.8878 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.19 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 653 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,563 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Mauritania?
- Reported number of people receiving antiretroviral therapy in Mauritania was 4,681 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Mauritania?
- The highest recorded value was 4,681 in 2025.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Mauritania?
- The lowest recorded value was 2 in 2000.
- How does Mauritania rank for reported number of people receiving antiretroviral therapy?
- Mauritania ranks 104th out of 143 countries with data for 2025.
- Is reported number of people receiving antiretroviral therapy rising or falling in Mauritania?
- Over the last ten years it is up 90.4%. The long-run trend across the full record is volatile.
- Where does this Mauritania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).